Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Coronis and Asklepios Cancer Research AB
AB
Active
Org 5593874844
Norr Mälarstrand 70, 112 35
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2022
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Coronis and Asklepios Cancer Research AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
271
41
Staff expenses
—
—
EBITDA
250
14
Depreciation & amort.
—
—
EBIT
250
14
Net financials
—
1
Profit before tax
250
15
Tax
−52
−3
Net profit
198
12
Balance sheet
SEK thousands
Item
2023
2024
Total assets
354
347
Equity
223
235
Long-term debt
—
—
Short-term debt
131
113
Total debt
131
113
Financial ratios
5-year trend
EBITDA margin
34.4%
This company
15.8%
Market median
+118% vs market
2023
2024
Equity ratio
67.5%
This company
38.2%
Market median
+77% vs market
2023
2024
Return on equity
5.0%
This company
18.4%
Market median
-73% vs market
2023
2024
Net profit margin
28.6%
This company
8.1%
Market median
+253% vs market
2023
2024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2023
2024
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-12-31
View
PDF
More on Coronis and Asklepios Cancer Research AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
